- Home
- ARQT vs LOMA Comparison
ARQT vs LOMA Comparison
Compare ARQT & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- LOMA
- Stock Information
- Founded
- ARQT 2016
- LOMA 1926
- Country
- ARQT United States
- LOMA Argentina
- Employees
- ARQT 342
- LOMA N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- LOMA Building Materials
- Sector
- ARQT Health Care
- LOMA Industrials
- Exchange
- ARQT Nasdaq
- LOMA Nasdaq
- Market Cap
- ARQT 2.0B
- LOMA 1.3B
- IPO Year
- ARQT 2020
- LOMA 2017
- Fundamental
- Price
- ARQT $16.87
- LOMA $11.69
- Analyst Decision
- ARQT Strong Buy
- LOMA Sell
- Analyst Count
- ARQT 6
- LOMA 2
- Target Price
- ARQT $18.80
- LOMA $6.55
- AVG Volume (30 Days)
- ARQT 2.7M
- LOMA 348.8K
- Earning Date
- ARQT 05-13-2025
- LOMA 03-06-2025
- Dividend Yield
- ARQT N/A
- LOMA N/A
- EPS Growth
- ARQT N/A
- LOMA 585.46
- EPS
- ARQT N/A
- LOMA 1.28
- Revenue
- ARQT $196,542,000.00
- LOMA $678,155,781.00
- Revenue This Year
- ARQT $56.60
- LOMA N/A
- Revenue Next Year
- ARQT $43.62
- LOMA N/A
- P/E Ratio
- ARQT N/A
- LOMA $8.73
- Revenue Growth
- ARQT 229.74
- LOMA N/A
- 52 Week Low
- ARQT $6.99
- LOMA $5.70
- 52 Week High
- ARQT $17.75
- LOMA $13.79
- Technical
- Relative Strength Index (RSI)
- ARQT 67.97
- LOMA 54.87
- Support Level
- ARQT $16.27
- LOMA $10.51
- Resistance Level
- ARQT $17.50
- LOMA $11.33
- Average True Range (ATR)
- ARQT 1.09
- LOMA 0.55
- MACD
- ARQT 0.25
- LOMA 0.12
- Stochastic Oscillator
- ARQT 94.23
- LOMA 100.00
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue Derives from Cement, masonry cement, and lime segment.